Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE‐BMT Risk Score
Journal of the American Heart Association · 02.01.2024 · 13 (1)
DOI: 10.1161/jaha.123.033599 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, erschienen am 02.01.2024. Verfasst von Alexi Vasbinder und 36 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Internal Medicine University of Michigan Ann Arbor MI. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Hematopoietic Stem Cell Transplantation, Heart Failure. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Evidence guiding the pre‐hematopoietic stem cell transplantation (HSCT) cardiovascular evaluation is limited. We sought to derive and validate a pre‐HSCT score for the cardiovascular risk stratification of HSCT candidates. Methods and Results We leveraged the CARE‐BMT (Cardiovascular Registry in Bone Marrow Transplantation) study, a contemporary multicenter observational study of adult patients who underwent autologous or allogeneic HSCT between 2008 and 2019 (N=2435; mean age at transplant of 55 years; 4.9% Black). We identified the subset of variables most predictive of post‐HSCT cardiovascular events, defined as a composite of cardiovascular death, myocardial infarction, heart failure, stroke, atrial fibrillation or flutter, and sustained ventricular tachycardia. We then developed a point‐based risk score using the hazard ratios obtained from Cox proportional hazards modeling. The score was externally validated in a separate cohort of 919 HSCT recipients (mean age at transplant 54 years; 20.4% Black). The risk score included age, transplant type, race, coronary artery disease, heart failure, peripheral artery disease, creatinine, triglycerides, and prior anthracycline dose. Risk scores were grouped as low‐, intermediate‐, and high‐risk, with the 5‐year cumulative incidence of cardiovascular events being 4.0%, 10.3%, and 22.4%, respectively. The area under the receiver operating curves for predicting cardiovascular events at 100 days, 5 and 10 years post‐HSCT were 0.65 (95% CI, 0.59–0.70), 0.73 (95% CI, 0.69–0.76), and 0.76 (95% CI, 0.69–0.81), respectively. The model performed equally well in autologous and allogeneic recipients, as well as in the validation cohort.
Conclusions
The CARE‐BMT risk score is easy to calculate and could help guide referrals of high‐risk HSCT recipients to cardiovascular specialists before transplant and guide long‐term monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Department of Internal Medicine University of Michigan Ann Arbor MI.
- Rush University Medical College, Rush University Chicago IL.
- Department of Pharmacy Rush University Medical Center Chicago IL.
- Department of Biostatistics, School of Public Health University of Michigan Ann Arbor MI.
- Division of Cardiology, Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA.
- Department of Internal Medicine University of Michigan Ann Arbor MI.
ORCID-Profile: Alexi Vasbinder, Elizabeth Anderson, Danielle Murphy, Halle Cheplowitz, Kristen Machado Diaz, Yiyuan Huang, Christopher W Hoeger, Rayan Kaakati, Hanna P Berlin, Husam Shadid, Daniel Perry, Michael Pan, Radhika Takiar, Jamie Mills, Pennelope Blakely, Mousumi Banerjee, Sarah Anand, Monalisa Ghosh, Attaphol Pawarode, Sunita Nathan, John Maciejewski, Tochukwu Okwuosa, Salim S Hayek
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Vasbinder, A., Catalan, T., Anderson, E., Chu, C., Kotzin, M., Murphy, D., Cheplowitz, H., Diaz, K. M., Bitterman, B., Pizzo, I., Huang, Y., Xie, J., Hoeger, C. W., Kaakati, R., Berlin, H. P., Shadid, H., Perry, D., Pan, M., Takiar, R., …, & Hayek, S. S. (2024). Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE‐BMT Risk Score. Journal of the American Heart Association, 13(1). https://doi.org/10.1161/jaha.123.033599
Vancouver
Vasbinder A, Catalan T, Anderson E, Chu C, Kotzin M, Murphy D, et al. Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE‐BMT Risk Score. Journal of the American Heart Association. 2024;13(1). doi:10.1161/jaha.123.033599
BibTeX
@article{Vasbinder2024,
author = {Vasbinder, Alexi and Catalan, Tonimarie and Anderson, Elizabeth and Chu, Catherine and Kotzin, Megan and Murphy, Danielle and Cheplowitz, Halle and Diaz, Kristen Machado and Bitterman, Brayden and Pizzo, Ian and Huang, Yiyuan and Xie, Jeffrey and Hoeger, Christopher W and Kaakati, Rayan and Berlin, Hanna P and Shadid, Husam and Perry, Daniel and Pan, Michael and Takiar, Radhika and Padalia, Kishan and Mills, Jamie and Meloche, Chelsea and Bardwell, Alina and Rochlen, Matthew and Blakely, Pennelope and Leja, Monika and Banerjee, Mousumi and Riwes, Mary and Magenau, John and Anand, Sarah and Ghosh, Monalisa and Pawarode, Attaphol and Yanik, Gregory and Nathan, Sunita and Maciejewski, John and Okwuosa, Tochukwu and Hayek, Salim S},
title = {Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE‐BMT Risk Score},
journal = {Journal of the American Heart Association},
year = {2024},
volume = {13},
number = {1},
doi = {10.1161/jaha.123.033599}
}
EUVIMED